Thiotepa Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-503

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Thiotepa (NDC 68083-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Thiotepa Spl Carton 100 mg

Thiotepa Spl Carton 100 mg
This is a pharmaceutical product labeled NDC 68083-503-01 for intravenous, intracavitary or intravesical use with caution for cytotoxic agents. The package comes in a single dose vial to be used as directed and contains 100 mg thiotepa USP after reconstituting with 10 mL of water for injection. It is important to read the package leaflet before use and to keep it away from children. They must be stored and transported refrigerated between 2°C and 8°C, taking care not to freeze. After reconstitution, the vial must be used within 8 hours when stored in a refrigerator, and once diluted, within 24 hours when stored in a refrigerator. The manufacturer is Gland Pharma Limited with code AP/DRUGS/03/2011 located in Visakhapatnam-530049, Andhra Pradesh, INDIA.*
FDA Label Image

Thiotepa Spl Carton 15 mg

Thiotepa Spl Carton 15 mg
Thiotepa is a prescription medication for intravenous, intracavity, or intravesical administration. It should be kept out of children's reach and stored properly during transportation. The packaging should be read before use. The drug is manufactured by lnd Prama Lintad, and each vial contains 15mg of Thiotepa. The prescription drug is to be administered by a qualified prescriber, and caution should be taken as the drug is a cytotoxic agent.*
FDA Label Image

Thiotepa Spl Container 100 mg

Thiotepa Spl Container 100 mg
This is a description of a medication with National Drug Code (NDC) 68083-503-01, which is for prescription use only. The drug is manufactured by Gland Pharma Limited in India and has a code of AP/DRUGS/03/2011. It comes in 100 mg/vial and can be used intravenously, intracavitary, or intravesical. The medication is a cytotoxic agent, and caution should be taken when handling it. The vial is single-dose, and any unused portion should be discarded. The measurements of the vial are 21x12 mm. The package includes a leaflet that should be read before using the medication, and the usual dosage should be taken as described in the accompanying Prescribing Information.*
FDA Label Image

Thiotepa Spl Container 15 mg

Thiotepa Spl Container 15 mg
Thiotepa is a cytotoxic agent available for intraveneous, intracavitary or intravesical use that comes in single-dose vials. Any unused portion should be discarded. The usual dosage should be determined by accompanying prescribing information. A package insert is available with further details. Manufactured by Sid B Limited with the code APIDRUGS/032011.*
FDA Label Image

Thiotepa-spl-structure (Thiotepa Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.